Biomarkers
Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson’s Disease: An Update
by Shemonti Hasan, MD; Charles H. Adler, MD, PhD; Nan
December 1, 2022
No Comments
by Shemonti Hasan, MD; Charles H. Adler, MD, PhD; Nan
by Amer Cavalheiro Hamdan, PhD, and Mariana Drabik Vieira, MSc
by Plamen Tzvetanov, MD, Phd, DSc, FRCP; Ivan Lisichkov, MD,
by Zeeshan Mansuri, MD, MPH; Abhishek Reddy, MD; Ramu Vadukapuram, MD;
Dear Editor: Parkinson’s disease (PD) affects over 600,000 patients in
by Monica Javidnia, PhD; Mark Frasier, PhD; Ira Shoulson, MD;
by Erika D. Driver-Dunckley, MD; Nan Zhang, MS; Holly A.
by Diksha Mohanty, MD, and Steven Lippmann, MD Dr. Mohanty
By Shivani Naik, MD; Murali Kolikonda, MD; Shanti Pittampalli, MD; Steven Lippmann, MD Funding/financial
by Sandeep Grover, MD; Aditya Somani, MD; Neeru Sahni, MD;
